Description

Erythromycin Gluceptate (200 Mg) is a water-soluble salt form of the macrolide antibiotic erythromycin, specifically designed for parenteral administration. This formulation is critical for delivering effective antibacterial therapy in clinical settings where oral administration is not feasible. It is an essential active pharmaceutical ingredient (API) primarily required by pharmaceutical manufacturers for the production of injectable antibiotic solutions targeting a broad spectrum of Gram-positive and some Gram-negative bacteria.

Application

• Injectable Pharmaceutical Formulations: Primary use as the active ingredient in sterile intravenous (IV) or intramuscular (IM) injections for systemic antibiotic treatment.
• Hospital & Clinical Use: Treatment of severe bacterial infections including pneumonia, Legionnaires' disease, pertussis, diphtheria, and pelvic inflammatory disease.
• Surgical Prophylaxis: Used in pre- and post-operative care to prevent surgical site infections, particularly for patients allergic to penicillin.
• Veterinary Medicine: Formulated for injectable antibiotic treatments in livestock and companion animals.
• Research & Development: Serves as a reference standard in pharmaceutical R&D, quality control laboratories, and microbiological studies.

Basic Information

Product Name	Erythromycin Gluceptate (200 Mg)
CAS No.	23067-13-2
Molecular Formula	C37H67NO13 • C7H14O7
Molecular Weight	960.1 g/mol (for erythromycin gluceptate)
Synonyms	Erythromycin Glucoheptonate; Erythromycin Gluceptate Salt; Erythromycin Glucoheptonic Acid Salt; Ilotycin Gluceptate; Erythrocin IV (branded form); ERY-007; AB-Fortisin; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione compound with D-glycero-D-gulo-heptonic acid
EINECS	Contact for details

Quality Control

Our Erythromycin Gluceptate is manufactured and tested to meet stringent pharmacopeial standards for pharmaceutical active ingredients. Each batch is subjected to comprehensive analytical testing including identification, assay, impurity profiling, sterility (where applicable), and endotoxin levels to ensure compliance with USP, EP, and cGMP guidelines. A detailed Certificate of Analysis (COA) documenting purity, potency, and all critical quality attributes is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation. For long-term stability, consider storage under inert atmosphere.

Specification

Item	Specification
Appearance	White or almost white, crystalline powder
Identification (IR)	Conforms to standard
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	97.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 5.0%
pH (5% solution)	6.5 - 7.5
Specific Optical Rotation	-71° to -78° (c=1 in water)
Related Substances (HPLC)	Total impurities ≤ 3.0% Any individual impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Bacterial Endotoxins	< 0.25 EU/mg (for injectable grade)

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.